PARP inhibitor (iPARP)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PARP inhibitor (iPARP), covering 2024-10-28 to 2024-10-28. Get the full timeline:
Most recent: Clinical Trial Update: Validation of KELIM as a Predictive/Prognostic Factor for Maintenance Treatment With iPARP in First-Line Ovarian Cancer